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ABSTRACT Schmallenberg virus (SBV) was discovered in Germany in late 2011 and
then spread rapidly to many European countries. SBV is an orthobunyavirus that
causes abortion and congenital abnormalities in ruminants. A virus-encoded non-
structural protein, termed NSs, is a major virulence factor of SBV, and it is known to
promote the degradation of Rpb1, a subunit of the RNA polymerase II (Pol II) com-
plex, and therefore hampers global cellular transcription. In this study, we found
that NSs is mainly localized in the nucleus of infected cells and speciﬁcally appears
to target the nucleolus through a nucleolar localization signal (NoLS) localized be-
tween residues 33 and 51 of the protein. NSs colocalizes with nucleolar markers
such as B23 (nucleophosmin) and ﬁbrillarin. We observed that in SBV-infected cells,
B23 undergoes a nucleolus-to-nucleoplasm redistribution, evocative of virus-induced
nucleolar disruption. In contrast, the nucleolar pattern of B23 was unchanged upon
infection with an SBV recombinant mutant with NSs lacking the NoLS motif
(SBVΔNoLS). Interestingly, unlike wild-type SBV, the inhibitory activity of SBVΔNoLS
toward RNA Pol II transcription is impaired. Overall, our results suggest that a puta-
tive link exists between NSs-induced nucleolar disruption and its inhibitory function
on cellular transcription, which consequently precludes the cellular antiviral response
and/or induces cell death.
IMPORTANCE Schmallenberg virus (SBV) is an emerging arbovirus of ruminants that
spread in Europe between 2011 and 2013. SBV induces fetal abnormalities during
gestation, with the central nervous system being one of the most affected organs.
The virus-encoded NSs protein acts as a virulence factor by impairing host cell tran-
scription. Here, we show that NSs contains a nucleolar localization signal (NoLS) and
induces disorganization of the nucleolus. The NoLS motif in the SBV NSs is abso-
lutely necessary for virus-induced inhibition of cellular transcription. To our knowl-
edge, this is the ﬁrst report of nucleolar functions for NSs within the Bunyaviridae
family.
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In 2011, a febrile syndrome was reported in adult dairy cows in Germany and theNetherlands and a novel virus, Schmallenberg virus (SBV), was discovered and found
to be pathogenic for ruminants (1). This newly identiﬁed virus belongs to the Orthobu-
nyavirus genus within the Bunyaviridae family. After its ﬁrst emergence in Northern
Europe, SBV rapidly spread across many European countries, causing a large epidemic
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(2). SBV predominantly affects domestic and wild ruminants and is transmitted by
multiple species of Culicoides biting midges (3–6). In pregnant females, transplacental
infection can lead to stillbirths and abortions or cause severe congenital malformations
in calves, lambs, and goat kids (1, 7, 8).
It is well established that the bunyavirus-encoded NSs protein contributes to viral
pathogenesis by inhibiting host cell transcription and consequently the innate antiviral
response (9–13). The role of SBV NSs as a virulence factor has been investigated using
an NSs deletion mutant (SBVΔNSs) produced by reverse genetics. In NIH-Swiss mice
inoculated by intracerebral route, SBVΔNSs showed an attenuated phenotype charac-
terized by a delay in the time of death in comparison to wild-type (WT) SBV (7). This
shows that SBV NSs plays a major role in viral pathogenesis. SBVΔNSs, in contrast to its
wild-type counterpart, is able to induce the synthesis of interferon (IFN) in several cell
lines, demonstrating that SBV NSs inhibits the host IFN response (7, 14). Interestingly,
SBV NSs is also able to trigger the proteasomal degradation of the Rpb1 subunit of RNA
polymerase II (Pol II) in vitro and subsequently to inhibit cellular transcription and
protein synthesis. The blockade of the IFN response by NSs may be a consequence of
this global inhibition of transcription (15). Besides, a transcriptomic study has shown in
vitro that SBV NSs causes a shutdown in the expression of genes involved in innate
immunity. Nevertheless, this shutdown is incomplete since a few antiviral genes are still
expressed following SBV infection (16). In addition, Barry et al. showed that SBV NSs
could enhance the rate of apoptotic cell death (15).
In the present study, we identiﬁed a nucleolar localization signal (NoLS) between
amino acids 33 and 51 (designated “aa 33–51” here) of SBV NSs that allows its
colocalization with naturally resident nucleolar proteins, such as B23 (nucleophosmin)
and ﬁbrillarin. Most importantly, wild-type SBV induces nucleolus-to-nucleoplasm re-
localization of B23 in several cell systems, including primary human neural progenitor
cells (hNPCs). In contrast, the distribution of this protein was unmodiﬁed in cells
infected with a mutant virus expressing an NSs variant lacking NoLS (SBVΔNoLS). We
also show that an NSsΔNoLS mutant protein could not inhibit a cytomegalovirus
(CMV)-driven promoter activity in comparison to its wild-type counterpart. To our
knowledge, this is the ﬁrst characterization of nucleolar targeting of a NSs protein from
bunyaviruses.
RESULTS
SBV NSs subcellular localization. The S segment of SBV encodes the nucleoprotein
N and the nonstructural protein NSs (Fig. 1A). NSs is encoded by an open reading frame
(ORF) between nucleotides 48 and 323 of the antigenomic RNA in position 1 with
respect to the ORF encoding the nucleoprotein N. NSs is poorly detected in SBV-
infected cells or in cells transiently transfected with NSs expression plasmids (15; this
work). This lack of expression might be partially attributed to an intrinsically unstable
nature of the protein, which often relies on the presence of disordered domains.
Indeed, in silico analyses performed with the PONDR-FIT software predict several
natively disordered regions along the primary amino acid sequence (Fig. 1B). Especially,
the N- and C-terminal ends of the protein as well as a central domain encompassing aa
33–51 appeared highly disordered, suggesting that NSs is an intrinsically unstructured
protein. In order to assess the respective contribution of the ordered/disordered
predicted regions in NSs expression and function, we generated expression plasmids
for NSs and NSs deletion mutants containing or not the disordered sequence from aa
33 to aa 51 (Fig. 1C). We also cloned the full-length nucleoprotein (N) ORF as a control.
All of these constructs were expressed as enhanced green ﬂuorescent protein (EGFP)
fusion proteins, and their expression was assessed by Western blotting (WB) upon
transfection of HEK 293T cells using an anti-EGFP antibody (Fig. 1D). Full-length
EGFP-NSs was mostly undetectable, although a very faint band could be inconstantly
observed in some experiments, while all other NSs mutants and the N protein were
detected in variable amounts. Then we assessed the intracellular distribution of these
constructs in HeLa cells (Fig. 1E). As expected, EGFP alone displayed a diffuse pattern
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throughout the cell, whereas EGFP-N mainly localized in the cytoplasm, as previously
described (15). All NSs constructs, including the previously poorly detected full-length
EGFP-NSs, were mostly present in the nucleus of transfected cells. Among those,
EGFP-NSs(1–51) and EGFP-NSs(33–51) proteins were observed in speciﬁc dense punc-
tate structures that were evocative of a nucleolar distribution. On the contrary, EGFP-
NSs(1–33) and EGFP-NSs(52–91) constructs which do not contain the aa 33–51 disor-
dered sequence are excluded from these subnuclear structures. Similar distribution
patterns were found when an ovine cell line and a bovine cell line were analyzed (data
not shown).
NSs contains a nucleolar localization signal (NoLS) and induces nucleolar
disorganization. The atypical subnuclear localization of EGFP-NSs(33–51) prompted us
to determine whether this chimeric protein was localized in nucleolar compartments.
Thus, we carried out ﬂuorescence microscopy in HeLa cells using the EGFP-NSs(33–51)
construct and the nucleolus-resident proteins B23 and ﬁbrillarin (Fig. 2A). EGFP-NSs(33–
51) strongly colocalizes with both B23 and ﬁbrillarin in transfected cells, indicating that
this domain acts as a nucleolar targeting sequence. A similar distribution pattern was
observed in ovine CPT-Tert cells and primary hNPCs (Fig. 2B). Then we searched for the
presence of a nucleolar localization signal (NoLS) in the NSs protein using the web
server NoD (http://www.compbio.dundee.ac.uk/nod) (17). Although no NoLS was rec-
ognized within NSs sequence, the graphical output of the NoLS score revealed a peak
(a value of 0.75) corresponding to a central region of the protein that almost reached
FIG 1 Expression and localization of SBV NSs mutants. (A) Schematic representation of SBV segment S (antigenomic
sense). The 5= and 3= noncoding regions are indicated in white. The open reading frame (ORF) of the N protein is
located between nucleotides 23 and 724. The NSs sequence is encoded by a 1 ORF between nucleotides 48 and
323. (B) Prediction of intrinsically disordered residues in SBV NSs using PONDR-FIT. The horizontal line at 0.5 of the
y axis represents the threshold for disordered/structured residues. Residues with a score above this line are
predicted to be disordered, and residues with a score below 0.5 are predicted to be ordered. (C) Schematic
representation of NSs constructs used in panels D and E. (D) HEK 293T cells were transfected with 500 ng pEGFP-C1,
pEGFP-N, or different pEGFP-NSs mutants as indicated. At 24 h posttransfection, cells were lysed, and lysates were
used for detection of EGFP constructs by Western blot analysis. -Actin was used as an internal control. (E) HeLa
cells were transfected as in panel D. Twenty-four hours posttransfection, cells were ﬁxed with 4% PFA and labeled
with DAPI (blue) to stain nuclei. Intracellular localization of EGFP constructs (green) was visualized by ﬂuorescence
microscopy (63 magniﬁcation). Scale bars represent 20 m.
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the positive predictive value (i.e., values of 0.80 considered positive) (Fig. 2C).
Interestingly, this region encompasses the aa 33–51 sequence that was seen in Fig. 1E
and 2A and -B to display nucleolar localization. These data demonstrate that the aa
33–51 domain of SBV NSs contains a functional NoLS.
In order to assess whether the full-length NSs is also present in the nucleolus,
ﬂuorescence microscopy was performed in HeLa and CPT-Tert cells and primary hNPCs
transfected with the pEGFP-NSs(1–91) plasmid (Fig. 3). The full-length EGFP-NSs was
predominantly observed in the nucleus of all cell types as described in the legend to
Fig. 1, but nucleolar localization was only partly recognized. Interestingly, B23 was
largely redistributed from the nucleolus to the nucleoplasm in cells expressing EGFP-
NSs. Altogether these results suggest that, once targeted to the nucleolus through an
internal NoLS motif, full-length NSs protein provokes nucleolar disorganization.
SBV triggers nucleolar disruption at an early stage during infection. To better
understand whether SBV perturbs nucleolus organization during infection, CPT-Tert
cells, hNPCs, and HeLa cells were infected with SBV (multiplicity of infection [MOI] of
0.01). Then the viral N protein and the nucleolus-resident protein B23 were detected at
20 h postinfection (p.i.) by ﬂuorescence microscopy (Fig. 4A). In all SBV-infected cell
types, B23 was fully redistributed throughout the nucleoplasm, while in mock-infected
and neighbor-uninfected cells, B23 displayed its typical nucleolar pattern. An alteration
of B23 localization was also induced by Shamonda virus (SHAV), while B23 distribution
pattern was unmodiﬁed in bluetongue virus (BTV)-infected cells, despite the fact the
NS4 protein of this virus localizes in the nucleolus (Fig. 4B). This suggests a putative
conserved mechanism between bunyavirus members of the Simbu serogroup.
FIG 2 NSs contains a nucleolar targeting domain. (A and B) HeLa and CPT-Tert cells and hNPCs were transfected with 500 ng
of pEGFP-NSs(33–51). At 24 h posttransfection, cells were ﬁxed with 4% PFA and labeled with DAPI to stain nuclei and with
speciﬁc antibodies for B23 and ﬁbrillarin (Fib). Intracellular localization of DAPI-stained nuclei (blue), EGFP-NSs(33–51) (green),
B23 and ﬁbrillarin (red) was visualized by ﬂuorescence microscopy (63 magniﬁcation). One cell per picture was enlarged on
the right side (yellow insets). Scale bars represent 20 m. (C) Graphic representation showing the average NoLS prediction
score in the SBV NSs protein using NoD, a nucleolar localization sequence detector. The horizontal red line at value 0.8 of the y
axis represents the threshold for NoLS prediction. Amino acid sequences with a score above this line are NoLS candidate
segment regions and represent the range of scores within which a 20-residue segment is predicted to be an NoLS. The blue
dotted line represents the score reached by SBV NSs, and the blue double-headed arrow indicates the aa 33–51 peptide
localization.
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To determine the timing of B23 redistribution during SBV infection, CPT-Tert cells
were mock infected or infected with SBV (MOI of 0.1) and ﬁxed at different times p.i.
(Fig. 5). As soon as 4 h p.i., nucleolar distribution of B23 was already moderately
altered and was completely redistributed in the nucleoplasm of SBV-infected cells
at 12 h p.i. Similar results were found when an MOI of 0.5 was used (data not
shown). These data strongly suggest that reorganization of the nucleolus occurs
early during SBV infection.
SBV-induced nucleolar disorganization precedes Rpb1 degradation. It has been
shown recently that transcription inhibition observed during SBV infection results from
the proteasomal degradation of the Rpb1 subunit of RNA Pol II, which started from 6
h p.i. and was maximal at 15 h p.i. (15). As nucleolar disorganization occurs early during
SBV infection, we wondered if this event can precede Rpb1 degradation. To address this
hypothesis, the expression of Rpb1 as well as the nucleolar protein B23 was ﬁrst
measured by Western blot analysis at different times p.i. as described in the legend to
Fig. 5. In SBV-infected CPT-Tert cells, the Rpb1 expression level started to decrease from
8 h to 12 h p.i. in comparison with that in mock-infected cells (Fig. 6A), which is in
accordance with previously published data (15). In contrast, the steady-state protein
level of B23 was unmodiﬁed at all considered time points p.i., suggesting that SBV
infection alters localization of B23 but not its expression.
Then we studied Rpb1 localization in SBV-infected cells at similar times p.i. (Fig.
6B). As expected, Rpb1 was found in the nucleus of mock-infected cells. In SBV-
infected cells, Rpb1 labeling started to decrease at 6 h p.i. and was poorly detected
or not detected at the subsequent time points p.i. The low proportion of SBV-
infected cells at 6 h p.i. could explain the lack of Rpb1 decrease at this time point
as measured by Western blotting. Altogether these results indicate that nucleolar
reorganization probably occurs a few hours before Rpb1 degradation during SBV
infection.
Mutations in NoLS sequence impair NSs nucleolar localization. We next sought
to identify the critical residues of the NSs(33–51) domain involved in nucleolar target-
ing. NoLS motifs are often enriched in basic residues (18). Interestingly, the NSs(33–51)
domain contains two close stretches of basic residues: RRR(39–41) and RRH(48–50)
(Fig. 7A). Thus, we aimed to assess the role of these positively charged residues in
nucleolar targeting by replacing them by alanine residues. Either the ﬁrst (NoLS 1), the
second (NoLS 2), or both (NoLS 12) basic stretches were modiﬁed within the pEGFP-
FIG 3 NSs triggers nucleolar reorganization. (A) HeLa and CPT-Tert cells and hNPCs were transfected with
500 ng of pEGFP-NSs(1–91). At 24 h posttransfection, cells were ﬁxed with 4% PFA and labeled with DAPI
to stain nuclei or stained with speciﬁc antibody for B23. Intracellular localization of DAPI-stained nuclei
(blue), EGFP constructs (green), and B23 (red) was visualized by ﬂuorescence microscopy (63 magni-
ﬁcation). Transfected cells are indicated using white arrows. Scale bars represent 20 m.
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NSs(1–91) plasmid construct. Cells transfected with either NoLS 1 or NoLS 2 mutants
showed a predominant nuclear distribution with no or poor nucleolar localization,
while the distribution of B23 appeared unaffected (Fig. 7B). Interestingly, the double
NoLS 12 mutant displayed nuclear distribution, but nucleolar localization was com-
pletely abolished, suggesting that both positively charged sites are important for
nucleolar targeting. These observations correlate with in silico analyses in which
mutations of both basic stretches appeared to be required to fully impair NoLS
prediction (0.15) (Fig. 7B, right).
In order to speciﬁcally address the importance of NSs-induced nucleolar disorgani-
zation in virus replication cycle, we aimed to produce a recombinant virus expressing
an NSs protein unable to reach the cell nucleolus. As N and NSs ORFs overlap on the
S segment, nucleotide changes introduced in the NSs ORF could have a detrimental
impact on N function and consequently on SBV replication. Computational predictions
suggested that the last two residues of NoLS 1 and the ﬁrst two residues of NoLS 2 were
the most critical residues for nucleolar targeting. Based on this assumption, we de-
signed an NSs mutant with predicted impaired nucleolar localization and low impact on
N ORF (Fig. 7C). We replaced RR residues in positions 41 and 42 (NoLS 1) with GG
residues and the RR residues in positions 48 and 49 (NoLS 2) with SL residues. While
these substitutions created three nonsynonymous mutations in the N ORF (R48K, R49K,
FIG 4 SBV and a Simbu-related virus trigger nucleolar reorganization during infection. (A) HeLa and CPT-Tert cells
and hNPCs were mock infected or infected with the SBV WT (MOI of 0.01). After overnight incubation, cells were
ﬁxed with 4% PFA and labeled with DAPI to stain nuclei or stained with speciﬁc antibodies for B23 and SBV N.
Intracellular localization of DAPI-stained nuclei (blue), B23 (red), and SBV N (green) was visualized by ﬂuorescence
microscopy (63 magniﬁcation). Scale bars represent 20 m. (B) HeLa cells were mock infected or infected with
either Shamonda virus (SHAV [left panel]) or bluetongue virus (BTV [right panel]). After overnight incubation, cells
were ﬁxed with 4% PFA and labeled with DAPI to stain nuclei or stained with speciﬁc antibodies for B23, N SHAV,
or NS3 BTV-8. Intracellular localization of DAPI-stained nuclei (blue), B23 (red), and SHAV N or BTV NS3 (green) was
visualized by ﬂuorescence microscopy (63 magniﬁcation). Scale bars represent 20 m.
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and T57S), the global charges and properties of the modiﬁed residues were preserved.
Site-directed mutagenesis was used to introduce these mutations within pEGFP-NSs(1–
91) to generate an EGFP-NSs(ΔNoLS) mutant. Fluorescence microscopy was then used
to study the subcellular localization of EGFP-NSs(ΔNoLS) (Fig. 7B, lower panel). As
predicted, EGFP-NSs(ΔNoLS) was found in the nucleus but not in the nucleolus, hence
validating the suppression of NSs NoLS function.
An SBV mutant lacking NoLS is impaired in nucleolar disruption. We then
generated a mutant virus, rSBVΔNoLS, harboring these mutations by reverse genetics.
We also rescued a wild-type SBV (rSBV WT) and rSBVΔNSs, an SBV recombinant mutant
virus lacking the entire NSs protein. rSBVΔNoLS displayed the same replication kinetics
FIG 5 SBV-induced nucleolar reorganization occurs early during infection. CPT-Tert cells were infected with SBV WT
(MOI of 0.1). At different time points p.i. (from 2 h to 12 h), cells were ﬁxed with 4% PFA to study the subcellular
localization of B23 and SBV N by ﬂuorescence microscopy. After ﬁxation, cells were labeled with DAPI to stain nuclei
and stained with speciﬁc antibodies for B23 and SBV N. Intracellular localization of DAPI-stained nuclei (blue), B23
(red), and SBV N (green) was visualized by ﬂuorescence microscopy (63 magniﬁcation). One cell per picture was
enlarged (yellow insets) to better assess gradual B23 relocalization. Scale bars represent 20 m.
FIG 6 SBV-induced nucleolar reorganization occurs earlier than Rpb1 degradation. (A and B) CPT-Tert
cells were infected with the SBV WT (MOI of 0.1). At different time points p.i. (from 2 h to 12 h), cells were
either lysed for B23, Rpb1, SBV N and -actin detection by Western blot analysis (A) or ﬁxed with 4% PFA
and subsequently labeled with DAPI to stain nuclei (blue) and stained with speciﬁc antibodies for Rbp1
(red) and SBV N (green). Scale bars represent 20 m (B).
SBV NSs Triggers Nucleolar Reorganization Journal of Virology
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and reached the same titers as rSBV WT and rSBVΔNSs in IFN-deﬁcient CPT-Tert cells
(Fig. 8A).
Then the rSBVΔNoLS mutant was used to assess the impact of NSs localization on
nucleolar organization during SBV infection. HeLa and CPT-Tert cells and hNPCs were
mock infected or infected with rSBV WT, rSBVΔNSs, or rSBVΔNoLS (MOI of 0.01) (Fig. 8B
to D). Cells were ﬁxed at 18 h p.i., and B23 was detected by ﬂuorescence microscopy.
In mock-infected cells, B23 displayed a typical nucleolar pattern. In all cell types
infected with rSBV WT, B23 was strongly redistributed throughout the nucleoplasm,
while it was unchanged in neighbor-uninfected cells. However, we did not observe any
redistribution of B23 in both rSBVΔNSs- and rSBVΔNoLS-infected-cells. Thus these data
demonstrate that NSs impairs the B23 natural distribution during SBV infection and NSs
nucleolar localization is necessary for this event.
NSs-induced transcriptional shutoff activity is hampered with NoLS mutants.
It has recently been shown that SBV NSs inhibits IFN synthesis, and as a consequence,
an SBV recombinant virus lacking NSs is attenuated in vivo (7, 19). Moreover, Barry et
al. found that NSs is able to block global cellular synthesis, including the antiviral
response (15). To assess the role of nucleolar localization in the ability of SBV NSs to
interfere with gene expression, HEK 293T cells were mock infected or infected with
rSBV, rSBVΔNSs, or rSBVΔNoLS (MOI of 0.1) and transfected with a plasmid expressing
ﬁreﬂy luciferase under the control of the CMV promoter, pCMV-Luc(Fireﬂy). Luciferase
activity was measured 24 h later (Fig. 9A). As expected, luciferase activity was strongly
FIG 7 Mutation of a putative nucleolar localization signal impairs NSs nucleolar localization. (A) Amino acid
sequence of the aa 33–51 region of SBV NSs. Bipartite triplet of basic residues corresponding to putative NoLS are
depicted in bold type and termed NoLS 1 and NoLS 2. (B) HeLa cells were transfected with pEGFP-NSs(1–91)
constructs mutated in NoLS 1, NoLS 2, both NoLS 1 and 2, and ΔNoLS as indicated. At 24 h posttransfection, cells
were ﬁxed with 4% PFA and labeled with DAPI to stain nuclei or stained with speciﬁc antibody for B23. Intracellular
localizations of EGFP constructs (green), DAPI-stained nuclei (blue), and B23 (red) were visualized by ﬂuorescence
microscopy (63 magniﬁcation). Scale bars represent 20 m. Each corresponding NoD graphic (right) shows the
average NoLS prediction score in the mutated SBV NSs protein. The horizontal red line at value 0.8 of the y axis
represents the threshold for NoLS prediction, and the blue dotted line represents the score reached by mutated
SBV NSs. (C) Amino acid sequence of the aa 37–51 region of NSs and aa 46–60 region of N. Minimal NoLS mutations
designed to be introduced in a recombinant virus were termed ΔNoLS and are depicted in bold type under the NSs
sequence. Modiﬁed amino acids in NSs sequence appear in bold type, and consecutive changes in N sequence are
represented in italic above the NSs sequence.
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inhibited in rSBV-infected cells (90% inhibition) compared to mock-infected cells. In
contrast, luciferase activity was partly restored in cells infected with rSBVΔNoLS (49%
inhibition) and to a lesser extent with rSBVΔNSs (74% inhibition). This suggests that the
NSs nucleolar localization is also needed to counteract RNA Pol II-driven cellular
FIG 8 A SBVΔNoLS mutant virus does not induce nucleolar reorganization. (A) Replication kinetics of rSBV WT, rSBVΔNSs, and
rSBVΔNoLS was assessed in CPT-Tert cells (MOI of 0.1). After infection, cell supernatants were collected from 8 h to 48 h p.i.
and the viral titers were obtained by limiting dilution assays in CPT-Tert cells. Each experiment was performed in triplicate, and
bars indicate the standard errors. (B to D) CPT-Tert cells (B), HeLa cells (C), and hNPCs (D) were mock infected or infected with
rSBV WT, rSBVΔNSs, and rSBVΔNoLS (MOI of 0.01). After 24 h of infection, cells were ﬁxed with 4% PFA and labeled with DAPI
to stain nuclei or stained with speciﬁc antibody for B23. Intracellular localization of DAPI-stained nuclei (blue), B23 (red), and
SBV N (green) was visualized by ﬂuorescence microscopy (63 magniﬁcation). Scale bars represent 20 m.
FIG 9 Involvement of the NoLS motif in NSs-induced cellular shutoff. (A) HEK 293T cells were not transfected (N.T.) or were
transfected with 100 ng of pCMV-Luc(Fireﬂy) reporter plasmid. After overnight incubation, cells were mock infected or infected
with rSBV, rSBVΔNSs, or rSBVΔNoLS. Cell lysates were harvested 24 h p.i. and used to determine luciferase activities. Mean
ratios of activities of triplicate samples were calculated and are presented as percentages of the mock control (standard
deviations). (B) HEK 293T cells were transfected with 250 ng of empty plasmid () or a plasmid encoding the 3FLAG-NSs WT
or NoLS 12 mutant together with 100 ng of the luciferase reporter plasmid pCMV-Luc(Fireﬂy). Cell lysates were harvested 24
h after transfection and used to determine luciferase activities. Mean ratios of activities of triplicate samples were calculated
and are presented as percentages of the control (standard deviations). Results are representative of one experiment and
were reproduced in three independent experiments. Statistically signiﬁcant differences are indicated: *, P  0.05; **, P  0.01,
and ***, P  0.001, by Student’s t test. N.S., not signiﬁcant.
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transcription. Moreover, Rpb1 as well as cellular RNA levels were unmodiﬁed in
rSBVΔNoLS-infected cells (data not shown). Then a similar experimental approach was
used to assess the effect of an NSs NoLS mutant on gene expression. We transfected
HEK 293T cells with pCMV-Luc(Fireﬂy) and plasmids encoding WT NSs or mutant NoLS
12 (Fig. 9B). As expected, the NSs(1–91) WT drastically repressed the activation of the
ﬁreﬂy luciferase gene expression driven by the CMV promoter. In contrast, luciferase
activity was fully restored in cells transfected with the NSs NoLS 12 mutant. Collec-
tively, these results suggest that gene expression shutoff exerted by SBV NSs might
require its proper localization to the nucleolus.
DISCUSSION
The NSs protein is a well-documented virulence factor within the Bunyaviridae that
interferes with the cellular antiviral responses at the transcriptional level to facilitate
viral replication and propagation. In particular, the Rpb1 subunit of RNA Pol II poly-
merase is targeted by several orthobunyaviruses, including the recently emerged SBV
(9, 15, 20–22). In this study, we found that the NSs protein of SBV contains a nucleolar
localization signal (NoLS) that is important for NSs function and disturbs the normal
distribution of nucleolus-resident proteins. While it is well known that the majority of
NSs proteins of bunyaviruses are nuclear proteins, to our knowledge, this is the ﬁrst
report of the presence of an NoLS within an NSs protein.
Until recently, the nucleolus was considered a subnuclear structure responsible for
rRNA synthesis and nascent ribosome assembly. Several proteomic studies have shown
that more than 6,000 resident or transitory proteins trafﬁc through the nucleolus. The
nucleolus is highly dynamic and plays fundamental roles in cellular stress responses,
innate immune responses, or cell cycle regulation (reviewed in reference 23). Given the
variety of key functions ensured by the nucleolus, many viruses that replicate in the
nucleus (DNA viruses, retroviruses, and some negative-stranded RNA viruses) have
usurped the nucleolus to favor their own replication (24–27). There are now many
examples of viral proteins targeting the nucleolus, but the molecular function behind
this localization is often uncertain or unresolved.
Most of the nucleolar proteins contain basic residue-rich sequences that act as
nucleolar localization signals (NoLSs), although a consensus NoLS motif(s) has not been
clearly deﬁned. This is possibly due to the huge range of interactors involved in
nucleolar localization. In this study, we found that the NSs region between amino acid
residues 33 and 51 of NSs speciﬁcally targets this protein to the nucleolus and therefore
acts as an NoLS. Fine dissection of this NoLS sequence allowed us to show that two
stretches of basic residues are crucial for nucleolar targeting. Nucleolar localization of
a protein is often governed by its association with another nucleolus-resident protein.
Alternatively, the protein can trafﬁc to the nucleolus on its own, where it associates
with protein(s) and/or ribosomal DNA (rDNA)/rRNA to be retained in this compartment.
NoLSs are often intimately associated with nuclear localization signals (NLSs) that are
also enriched in basic residues and mediate active transport of proteins through the
nuclear pore complex (28). We now aim to decipher the sequences involved in the
nuclear import of NSs. We believe that NSs could trafﬁc actively between the cytoplasm
and the nucleus, while the NoLS functions more as a retention signal (unpublished
data).
In our study, we found that SBV infection or NSs overexpression triggered the
redistribution of B23 throughout the nucleoplasm. On the other hand, NoLS mutation
in SBV NSs impaired NSs-induced transcription shutdown. These results raise the
question about the link between nucleolar localization of NSs and transcription inhi-
bition. Among the multiple strategies evolved by viruses to interfere with the host
transcription machinery (29), nucleolar targeting is a common mechanism shared by
several picornaviruses (24, 30). Indeed, the 3Cpro protease of poliovirus blocks RNA Pol
I synthesis through modiﬁcation and inactivation of factors essential for rRNA tran-
scription, upstream binding factor (UBF) and selectivity factor 1 (SL1) possibly involving
its proteolytic activity (31). The encephalomyocarditis virus encodes several proteins
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(2A, 3BVPg, 3Cpro, and 3Dpol) that also localize to the nucleolus at an early stage during
infection (32). Although elucidation of the precise molecular mechanisms of the
shutdown of cellular transcription by picornaviruses awaits further research, the nucle-
olus is clearly a primary interface in this process. In parallel, several studies showed that
transcription inhibition can induce nucleolar disruption (reviewed in reference 33).
Here, we found that nucleolar reorganization observed during SBV infection might
occur slightly before Rpb1 degradation. However, we cannot rule out the possibility
that RNA polymerase II activity might be block at an earlier time point. Thus, although
the data presented in this article clearly show the requirement of an intact NoLS motif
on NSs to ensure its intact subcellular localization and inhibitory function on RNA
synthesis, further experiments are needed to decipher the exact molecular mechanisms
involved in these events.
To date, only two other viral proteins have been reported to trigger Rpb1 degra-
dation during infection: the NSs protein of the SBV-related orthobunyavirus La Crosse
virus (LACV) (9) and the NSP2 protein of alphaviruses (34). This degradation seems to
be linked to the blockade of cellular antiviral responses described for these proteins (9,
12, 35). Strikingly, the NSP2 protein encoded by the alphavirus Semliki Forest virus (SFV)
is targeted to the nucleolus (36). Although the NoLS of SBV NSs is not fully conserved
with LACV NSs, it would be interesting to assess whether the latter could also be
addressed to the nucleolus through a speciﬁc sequence.
In an attempt to identify determinants of SBV virulence, Varela et al. serially
performed extensive passage and plaque puriﬁcation of SBV in CPT-Tert cells. They
unexpectedly obtained an SBV mutant (SBVp32) with increased pathogenicity upon
inoculation to newborn NIH-Swiss mice intracerebrally (7). SBVp32 accumulated 17
nucleotide changes among the three genome segments, with most of mutations
identiﬁed within the M and S segments. By in vivo assays, they recently found that the
M segment contains the determinants of virulence of SBVp32. In contrast, a reassortant
containing the S segment of SBVp32 and the remaining genome segments from the
SBV wild type is attenuated in vivo. Importantly, this naturally attenuated mutant
harbors a nonsynonymous change at nucleotide 167, which induces a mutation in the
ﬁrst basic stretch of the NoLS motif, which is critical for nucleolar localization of NSs
(37). The role of this natural in vitro-occurring mutation in SBV virulence has not
speciﬁcally been addressed, but it underlines the importance of the NSs NoLS sequence
in the SBV life cycle. Preliminary data suggest that the replication of the rSBVΔNoLS
recombinant virus is impaired in IFN-competent cells, as previously observed with an
SBVΔNSs mutant (7, 15), especially at late time points (data not shown). Thus, further
work will be required to precise role of the NSs NoLS motif in the cellular antiviral
response and in SBV attenuation.
Among the wide range of lesions that have been reported in SBV-infected fetuses
and newborns, the central nervous system (CNS) constitutes a privileged target (7,
38–41). Indeed, loss of neural cells, and especially progenitor cells that give rise to
precursors of neuronal and glial cell populations, is suspected to play a major role in
SBV pathogenesis in domestic ruminants (E. Laloy, unpublished data). Whether cell loss
either results from a direct SBV-driven cytopathic effect or is the consequence of an
ischemic/inﬂammatory response requires further investigations. However, the presence
of SBV antigens in neurons of associated lesions is in favor of the former hypothesis (7,
38, 39). Similarly Akabane virus is able to infect neuronal and astroglial cells, which led
to degenerative death (42). In this study, we were able to demonstrate that SBV
replicates efﬁciently in a model of primary human neural progenitor cells (hNPCs) and
that NSs is highly efﬁcient in these cells to relocate nucleolar proteins. It is interesting
to note that recent ﬁndings point toward novel functions of the nucleolus in neuronal
disorders (43, 44). This strengthens the putative link between NSs-triggered nucleolar
alteration and SBV pathogenesis.
In conclusion, the present article clearly shows that the NSs protein of SBV is
targeted to the nucleolus by an NoLS identiﬁed in the central region of the protein. The
presence of NSs in the nucleolar compartment causes a nucleolar stress pointed out by
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the relocalization of nucleolar proteins. We cannot rule out that NSs possesses other
biological functions outside the nucleolus, but we think that nucleolar stress is the main
driver for NSs to prompt transcriptional shutoff and, therefore, provide the molecular
basis explaining the role of SBV NSs as a virulence factor.
MATERIALS AND METHODS
Cells. HeLa cells (kindly provided by Damien Arnoult, Inserm U1014, Hôpital Paul Brousse, Villejuif,
France), HEK 293T cells, Vero cells (kindly provided by Pierre-Olivier Vidalain, UMR8601, CNRS-Université
Paris-Descartes, Paris, France), and BSR-T7/5 cells (kindly provided by Jean-François Eleouët, INRA VIM,
Jouy-en-Josas, France) were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM [Gibco]) supple-
mented with 10% heat-inactivated fetal calf serum (FCS [Eurobio]), and 1% sodium pyruvate with 100
IU/ml penicillin plus 100 g/ml streptomycin (P-S [Gibco]). BSR T7/5 cells stably expressing the T7
polymerase were cultured in the presence of G418 (ﬁnal concentration of 50 g/ml) every ﬁve passages
to maintain T7 expression. BHK-21 cells (kindly provided by the National Reference Laboratory for
Orbiviruses, Laboratory for Animal Health, ANSES, Maisons-Alfort, France) were grown in Glasgow MEM
(GMEM [Sigma-Aldrich]) supplemented with tryptose phosphate broth, 10% FCS, and P-S. The ovine
CPT-Tert cell line (kindly provided by David Grifﬁths, Moredun Research Institute, Penicuik, UK) derives
from choroid plexus cells (45) and was grown in Iscove’s modiﬁed Dulbecco’s medium (IMDM [Sigma-
Aldrich]) supplemented with 10% FCS, 1% sodium pyruvate, 1 mM nonessential amino acids, and P-S.
Human neural progenitor cell cultures (hNPCs) were prepared from human fetal brains (ﬁrst trimester
stage [see references 46 and 47 for details]). hNPCs were maintained in advanced DMEM–F-12 (Invitrogen
Life Technologies) supplemented with L-glutamine (2 mM [Gibco]), apotransferrin (0.1 mg/ml [Sigma-
Aldrich]), insulin (25 g/ml [Sigma-Aldrich]), and progesterone (6.3 ng/ml [Sigma-Aldrich]). Medium was
changed 3 times a week, and epidermal growth factor and basic ﬁbroblast growth factor (both at 20
ng/ml [Abcys]) were added to maintain undifferentiated cells. All cells were cultured at 37°C in 95%
air–5% CO2.
Viruses and infections. The wild-type SBV viral strain was isolated from the brain of a stillborn
malformed lamb in the department of Moselle in France in 2012 (UMR1161 Virology Collection, ANSES,
Maisons-Alfort, France). Virus titers were determined by standard plaque assays or endpoint dilution in
CPT-Tert cells and expressed as PFU per milliliter or 50% tissue culture infective dose (TCID50) per
milliliter. Shamonda virus (SHAV) was kindly provided by Philippe Despres (Institut Pasteur, France). The
wild-type ﬁeld strain of bluetongue virus serotype 8 (BTV-8) was isolated in the department of Ardennes
in 2006 (48). Infections were performed with subconﬂuent HeLa and CPT-Tert cells or hNPCs. Cells were
washed in serum-free medium and then inoculated with the viral inoculum at a multiplicity of infection
(MOI) of 0.01 or 0.1/cell diluted in serum-free medium. Serum-free medium was used as an inoculum for
mock-infected cells. After 1 h of incubation at 37°C while stirring, the inoculum was discarded, and fresh
medium supplemented with 10% FCS was added to cell cultures. After infection, cells were analyzed at
the indicated time points by ﬂuorescence microscopy or Western blotting.
Plasmids. DNA sequences containing full-length open reading frames (ORFs) of SBV N, NSs(1–91), or
NSs deletion mutants corresponding to aa 1 to 33, 1 to 51, 52 to 91, or 33 to 51 were ampliﬁed by PCR
and cloned by in vitro recombination into pDONR207 (Gateway system; Invitrogen) as described in
references 49 and 50). These SBV coding sequences were subsequently recombined into the pEGFP-C1
or pCINeo-3FLAG modiﬁed vectors using the Gateway cloning procedure to generate fusion proteins
downstream of EGFP (pEGFP-N/NSs constructs) or 3FLAG (pF-NSs constructs), respectively (50). NoLS
mutants on NSs full-length plasmid constructs were generated by site-directed mutagenesis following
the manufacturer’s instructions (QuikChange II site-directed mutagenesis [Agilent]). The pCMV-
Luc(Fireﬂy) luciferase reporter plasmid was kindly provided by Frédérick Arnaud (UMR754 INRA-UCBL-
EPHE). The pUCSBVST7, pUCSBVMT7, pUCSBVLT7, and pUCSBVΔNSsT7 plasmids encoding antigenomic
viral S, M, L, and SΔNSs segments, respectively, were used to generate recombinant wild-type (rSBV) and
ΔNSs (rSBVΔNSs) viruses as described in reference 7. pUCSBVΔNoLST7 was obtained by introducing 4
codon changes in pUCSBVST7 by site-directed mutagenesis to abolish the NSs nucleolar localization
signal (Fig. 7).
Transfections. All transfections were performed with JetPRIME (Polyplus) according to the manu-
facturer’s instructions.
Reverse genetics. The recombinant rSBV WT, rSBVΔNSs, and rSBVΔNoLS viruses were generated
using the SBV reverse-genetics protocols described in reference 7. Brieﬂy, BSR-T7/5 cells were transfected
with 750 g of each plasmid carrying the antigenome. Supernatants were collected 5 days posttrans-
fection, and the titers of the rescued viruses were determined by plaque assays in CPT-Tert cells.
Virus replication kinetics. To assess the replication kinetics of recombinant SBV viruses, 24-well
plates were seeded with 1  105 CPT-Tert cells/well, and the cells were infected at an MOI of 0.01. Cell
supernatants were collected at several time points postinfection (p.i.) and used to estimate the presence
of infectious viral particles by endpoint dilution performed in CPT-Tert cells.
Computational analyses. PONDR-FIT, a meta-predictor of intrinsically disordered residues, was used
to predict the disordered region(s) in the NSs amino acid sequence (available at www.disprot.org) (51).
Prediction of nucleolar localization sequences was performed using the web server NoD (available at:
http://www.compbio.dundee.ac.uk/www-nod/) (17).
Antibodies. SBV infection was detected using a rabbit polyclonal antiserum raised against the SBV
N protein expressed as a His-tagged recombinant protein from baculovirus in insect cell line Sf9 (Western
blotting [WB], 1:1,000; immunoﬂuorescence [IF], 1:500) (UMR1161 Virology, ANSES, Maisons-Alfort,
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France). N and NSs proteins expressed in fusion downstream of EGFP were detected using mouse
monoclonal anti-GFP antibody (Roche Life Science; reference no. 11814460001 [WB, 1:2,000]). Monoclo-
nal anti-B23 (reference no. B0556 [WB, 1:10,000; IF, 1:1,000]) and antiactin (clone AC-40; reference no.
A3853 [WB 1:2,500]) antibodies were purchased from Sigma-Aldrich. Mouse monoclonal antibody against
ﬁbrillarin used in this study was from Abcam (IF, 1:250). Mouse anti-Rpb1 monoclonal antibody was
purchased from Ozyme (clone 8WG16; reference no. BLE92010 [WB, 1:500; IF, 1:250]).
Luciferase reporter assays. The effect of NoLS mutations on NSs-driven inhibition of gene expres-
sion was assessed using luciferase reporter assays. Brieﬂy, 7  105 HEK 293T cells were transfected with
250 ng of empty plasmid () or plasmids encoding 3FLAG-NSs WT or the NoLS 12 mutant together
with 100 ng of the luciferase reporter plasmid pCMV-Luc(Fireﬂy). Cells were incubated for 24 h and then
lysed in luciferase lysis buffer (25 mM Tris [pH 7.8], 0.8 mM MgCl2, 0.1% Triton X-100, 15% glycerol). Fireﬂy
luciferase activity was determined using the Bright-Glo luciferase assay system (Promega). Each exper-
iment was performed in triplicate at least three times independently. Mean ratios of activities of triplicate
samples were calculated and presented as percentages of the control (standard deviations). To assess
the effect of SBV mutant viruses on the CMV promoter, 24-well plates were seeded with 7  105 HEK
293T cells, and the cells were mock infected or infected with rSBV WT, SBVΔNSs, and SBVΔNoLS (MOI of
0.1). Immediately after infection, cells were transfected with 100 ng of pCMV-Luc(Fireﬂy) and analyzed as
described above.
Immunoﬂuorescence assays. Twelve-millimeter-diameter coverslips in 24-well plates were seeded
with CPT-Tert (2  105) or HeLa (1  105) cells. Twenty-four-well glass plates (Ibidi -plates, BioValley)
precoated with Matrigel (1:1,000 [Corning, France]) were directly seeded with hNPCs (1  105). After
transfection and/or infection, cells were washed 3 times in phosphate-buffered saline (PBS) and ﬁxed
with 4% paraformaldehyde (PFA [Electron Microscopy Sciences]) in PBS for 20 min at room temperature.
Cells were permeabilized with 0.5% Triton X-100 in PBS and incubated in blocking buffer (1% bovine
serum albumin in PBS). The appropriate dilution of primary antibodies was then added for 1 h at room
temperature. Cells were then washed three times in PBS, and Alexa Fluor 488 anti-mouse and Alexa Fluor
555 anti-rabbit secondary antibodies (Molecular Probes) were used to detect bound primary antibodies.
Samples were mounted in Mowiol containing DAPI (4,6=-diamidino-2-phenylindole) for staining of nuclei
(Sigma-Aldrich). Microscopy studies were carried out with an Axio observer Z1 ﬂuorescence inverted
microscope (Zeiss), and images were acquired using the Zen 2012 software and analyzed with ImageJ.
Each experiment was reproduced at least 3 times.
Western blot analysis. Cells were harvested in lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl,
1% Triton X-100, and 10% glycerol supplemented with a cocktail of protease inhibitors according to the
manufacturer’s instructions (Complete EDTA-free [Roche Life Science]). Insoluble material was centri-
fuged at 10,000  g for 15 min at 4°C, and the supernatant was kept as the soluble fraction. The total
protein concentration of the soluble fraction was determined by a micro-bicinchoninic acid (micro-BCA)
assay (Thermo Fisher). Protein extracts were reduced by being heated at 95°C for 5 min in the presence
of denaturing agent, and an equal amount of proteins was resolved by 10% to 15% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by transfer to nitrocellulose membrane
(Hybond-ECL; Amersham Biosciences). Membranes were blocked with phosphate-buffered saline (PBS)
containing 5% dry milk and 0.1% Tween 20 and incubated with the required dilution of speciﬁc
antibodies. Bound primary antibodies were detected using horseradish peroxidase-conjugated anti-
rabbit or anti-mouse secondary antibodies (Dako [diluted 1:5,000]) and an enhanced luminol-based
chemiluminescent detection system (ECL clarity; Bio-Rad).
Statistical analyses. Statistical analyses were conducted with the Student t test. Differences were
considered to be signiﬁcant if the P value was 0.05.
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